FDA Advising of Risk of Birth Defects with Paxil

Armen Hareyan's picture
Advertisement

Pregnancy and Paxil

The Food and Drug Administration today is alerting health care professionals and patients about early results of new studies for Paxil (paroxetine) suggesting that the drug increases the risk for birth defects, particularly heart defects, when women take it during the first three months of pregnancy.

Advertisement